Yehan Zhou

No.55, Renmin South Road
Chengdu, 610041, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Development and temporal validation of an ultrasound-adapted station 104 risk stratification framework for supraclavicular nodal staging in ESCC.

Development and temporal validation of an ultrasound-adapted station 104 risk stratification framework for supraclavicular nodal staging in ESCC.

Journal: European journal of radiology

Published: May 15, 2026

Deoxylapachol inhibits esophageal squamous cell carcinoma progression via targeting FOXM1-mediated Wnt/β-catenin pathway.

Deoxylapachol inhibits esophageal squamous cell carcinoma progression via targeting FOXM1-mediated Wnt/β-catenin pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 01, 2025

Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study).

Neoadjuvant chemotherapy or chemoradiotherapy plus sintilimab versus neoadjuvant chemoradiotherapy for locally advanced oesophageal squamous cell carcinoma: a study protocol of a multicentre, randomised, controlled, phase III trial (SCIENCE study).

Journal: BMJ open

Published: June 04, 2025

Deep Learning-Guided Quantitative Analysis Establishes Optimized BRAF V600E Immunohistochemical Criteria for Colorectal Cancer: A Multiplatform Validation Study.

Deep Learning-Guided Quantitative Analysis Establishes Optimized BRAF V600E Immunohistochemical Criteria for Colorectal Cancer: A Multiplatform Validation Study.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 08, 2025

Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma.

Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma.

Journal: The oncologist

Published: February 18, 2025

Impact of perineural invasion in thoracic esophageal squamous cell carcinoma-a retrospective study with long-term follow-up outcomes.

Impact of perineural invasion in thoracic esophageal squamous cell carcinoma-a retrospective study with long-term follow-up outcomes.

Journal: Journal of thoracic disease

Published: November 24, 2024

Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant.

Enhanced prognosis prediction model in esophageal cancer via lymph node assessment post-neoadjuvant.

Journal: BMC cancer

Published: August 24, 2024

Application of Different Staining Methods in the Diagnosis of Pigment-Rich Melanoma.

Application of Different Staining Methods in the Diagnosis of Pigment-Rich Melanoma.

Journal: Journal of clinical laboratory analysis

Published: July 12, 2024

Alkannin Induces G2/M-Phase Arrest, Apoptosis, and Inhibition of Invasion by Targeting GSK3β in Esophageal Squamous Cell Carcinoma.

Alkannin Induces G2/M-Phase Arrest, Apoptosis, and Inhibition of Invasion by Targeting GSK3β in Esophageal Squamous Cell Carcinoma.

Journal: Drug design, development and therapy

Published: June 17, 2024

Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.

Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis.

Journal: BMC cancer

Published: May 05, 2024

Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis.

Long-term outcomes of smoker and drinker with oesophageal squamous cell carcinoma after oesophagectomy: a large-scale propensity score matching analysis.

Journal: BMJ open gastroenterology

Published: April 25, 2024

Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.

Toripalimab plus chemotherapy and radiotherapy for treatment-naive advanced esophageal squamous cell carcinoma: a single-arm phase 2 trial.

Journal: Nature communications

Published: March 03, 2024

Showing 1-12 of 23

Last Updated: 09/26/2026